New drug combo shows promise for Hard-to-Treat cancers
NCT ID NCT05941507
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 22 times
Summary
This study tests a new drug called LCB84, which targets a protein (TROP2) on cancer cells, for people with advanced solid tumors that have stopped responding to standard treatments. The drug is given alone or with another drug that boosts the immune system. The goal is to find safe doses and see if the combination can shrink tumors or slow their growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
Contact
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Email: •••••@•••••
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mary Crowley Cancer Research
RECRUITINGDallas, Texas, 75230, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tennessee Oncology
NOT_YET_RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Texas Southwestern Medical Center
NOT_YET_RECRUITINGDallas, Texas, 75390, United States
Contact
Conditions
Explore the condition pages connected to this study.